Biodexa Pharmaceuticals (BDRX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    5.23
    -0.09 (-1.69%)
    At close: Sep 09, 2025, 11:33 AM

    Biodexa Pharmaceuticals Cash Flow Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -5.73M -7.08M -7.66M -5.46M
    Depreciation & Amortization
    		 254K 283K 343K 403K
    Stock-Based Compensation
    		 283K 28K 123K 89K
    Other Working Capital
    		 2.24M -414K 513K -130K
    Other Non-Cash Items
    		 -3.08M 397K 454K -892K
    Deferred Income Tax
    		 -250K -406K -832K 469K
    Change in Working Capital
    		 -3.74M -49K 520K -617K
    Operating Cash Flow
    		 -12.26M -6.83M -7.05M -6.01M
    Capital Expenditures
    		 -774K -263K -62K -320K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 -589K -239K -158K 42K
    Investing Cash Flow
    		 -598K -265K -220K -278K
    Debt Repayment
    		 245K -188K -178K -215K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a -13K -18K -15K
    Financial Cash Flow
    		 8.56M 10.23M 47K 8.8M
    Net Cash Flow
    		 -4.3M 3.13M -7.22M 2.51M
    Free Cash Flow
    		 -13.04M -7.09M -7.11M -6.33M

    Add to Watchlist